KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Change in Cash (2016 - 2025)

Merck (MRK) has disclosed Change in Cash for 17 consecutive years, with -$3.6 billion as the latest value for Q4 2025.

  • On a quarterly basis, Change in Cash fell 160.58% to -$3.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.4 billion, a 78.59% decrease, with the full-year FY2025 number at $1.4 billion, down 78.59% from a year prior.
  • Change in Cash was -$3.6 billion for Q4 2025 at Merck, down from $10.2 billion in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $10.2 billion in Q3 2025 to a low of -$4.6 billion in Q1 2025.
  • A 5-year average of $326.8 million and a median of -$106.0 million in 2022 define the central range for Change in Cash.
  • Peak YoY movement for Change in Cash: tumbled 768.23% in 2023, then surged 239.96% in 2024.
  • Merck's Change in Cash stood at -$1.9 billion in 2021, then soared by 179.51% to $1.5 billion in 2022, then tumbled by 217.8% to -$1.8 billion in 2023, then rose by 22.16% to -$1.4 billion in 2024, then tumbled by 160.58% to -$3.6 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Change in Cash are -$3.6 billion (Q4 2025), $10.2 billion (Q3 2025), and -$659.0 million (Q2 2025).